Tianda Pharmaceuticals (HKSE:00455) Long-Term Capital Lease Obligation : HK$3.1 Mil (As of Dec. 2023)

View and export this data going back to 1992. Start your Free Trial

What is Tianda Pharmaceuticals Long-Term Capital Lease Obligation?

Tianda Pharmaceuticals's Long-Term Capital Lease Obligation for the quarter that ended in Dec. 2023 was HK$3.1 Mil.

Tianda Pharmaceuticals's quarterly Long-Term Capital Lease Obligation declined from Sep. 2022 (HK$9.7 Mil) to Jun. 2023 (HK$5.8 Mil) and declined from Jun. 2023 (HK$5.8 Mil) to Dec. 2023 (HK$3.1 Mil).

Tianda Pharmaceuticals's annual Long-Term Capital Lease Obligation declined from Mar. 2021 (HK$11.7 Mil) to Mar. 2022 (HK$7.9 Mil) and declined from Mar. 2022 (HK$7.9 Mil) to Dec. 2023 (HK$3.1 Mil).

Tianda Pharmaceuticals Long-Term Capital Lease Obligation Historical Data

The historical data trend for Tianda Pharmaceuticals's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tianda Pharmaceuticals Long-Term Capital Lease Obligation Chart

Tianda Pharmaceuticals Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Dec23

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

0.69

11.65

7.94

3.07

Tianda Pharmaceuticals Semi-Annual Data
	Mar14	Sep14	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Jun23	Dec23
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial															10.20	7.94	9.73	5.80	3.07

Tianda Pharmaceuticals (HKSE:00455) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Tianda Pharmaceuticals Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Tianda Pharmaceuticals's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Tianda Pharmaceuticals (HKSE:00455) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tianda Pharmaceuticals Ltd (HKSE:00455) » Definitions » Long-Term Capital Lease Obligation

Traded in Other Exchanges

N/A

Address

CITIC Tower, No. 1 Tim Mei Avenue, Suites 2405-2410, 24th Floor, Central, Hong Kong, HKG

Website

https://www.tiandapharma.com

Tianda Pharmaceuticals Ltd is engaged in R&D, manufactures and sales of pharmaceutical, biotechnology and healthcare products. The group also engages in R&D of Chinese medicine and manufacture and sales of Chinese medicine products, and the provision of Chinese medical services. Its operating segments include Chinese medicine business; Medical and healthcare services; and Pharmaceuticals and medical technologies business. The company derives majority of the revenue from Pharmaceuticals and medical technologies business.

Executives

Tianda Group Limited	2101 Beneficial owner
Fang Wen Quan	2201 Interest of corporation controlled by you

Tianda Pharmaceuticals (HKSE:00455) Headlines

No Headlines